BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

CAT Outbid In Acquisition of DRC, Will Buy Back Royalties

March 13, 2002
By Nuala Moran

Ionix, Xenome Enter Deal To Screen Toxin Peptides

March 13, 2002
By Nuala Moran

CAT Appears Out Of Running In Bid To Acquire Drug Royalty

March 12, 2002
By Nuala Moran

CAT Appears Out Of Running In Bid To Acquire Drug Royalty

March 12, 2002
By Nuala Moran

UK Government OKs Research Involving Embryonic Stem Cells

March 6, 2002
By Nuala Moran
LONDON - The UK government has removed the last legal barrier to stem cell research using human embryos, paving the way for the UK to take the lead in this field as the only country with a precise regulatory framework governing such research. (BioWorld International)
Read More

AM-Pharma Completes Venture Round To Move Drugs Forward

March 6, 2002
By Nuala Moran

Celltech Plans Crohn’s Phase III Despite Non-Significant Phase II

March 6, 2002
By Nuala Moran

AM-Pharma Completes Venture Round To Move Drugs Forward

March 6, 2002
By Nuala Moran

Celltech Plans Crohn’s Phase III Despite Non-Significant Phase II

March 6, 2002
By Nuala Moran

UK Government OKs Research Involving Embryonic Stem Cells

March 6, 2002
By Nuala Moran
LONDON - The UK government has removed the last legal barrier to stem cell research using human embryos, paving the way for the UK to take the lead in this field as the only country with a precise regulatory framework governing such research. (BioWorld International)
Read More
Previous 1 2 … 508 509 510 511 512 513 514 515 516 … 529 530 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing